Dry powder inhaler formulations The influence of engineered lactose crystals upon the deposition of salbutamol sulphate
Larhrib, H.; Martin, G.P.; Marriott, C.; Prime, D.
Journal of Pharmacy and Pharmacology 52(Suppl): 14
2000
ISSN/ISBN: 0022-3573 Accession: 034770493
PDF emailed within 1 workday: $29.90
Related References
Larhrib, H.; Martin, G.P.; Prime, D.; Marriott, C. 2003: Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 19(4): 211-221Kaialy, W.; Ticehurst, M.; Nokhodchi, A. 2012: Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate International Journal of Pharmaceutics 423(2): 184-194
Kaialy, W.; Momin, M.N.; Ticehurst, M.D.; Murphy, J.; Nokhodchi, A. 2010: Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler Colloids and Surfaces. B Biointerfaces 79(2): 345-356
Kaialy, W.; Nokhodchi, A. 2013: Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations Aaps Journal 15(3): 728-743
Zeng, X.M.; Martin, G.P.; Tee, S.K.; Ghoush, A.A.; Marriott, C. 1999: Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation International Journal of Pharmaceutics 182(2): 133-144
Guchardi, R.; Frei, M.; John, E.; Kaerger, J.S. 2008: Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations International Journal of Pharmaceutics 348(1-2): 10-17
Corrigan, D.O.; Corrigan, O.I.; Healy, A.M. 2006: Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers International Journal of Pharmaceutics 322(1-2): 22-30
Peltonen, J; Alanen, O; Mäkilä, E; Murtomaa, M; Salonen, J 2017: Influence of relative humidity on the electrostatic charging of lactose powder mixed with salbutamol sulphate Journal of Electrostatics 88: 201-206
Kaialy, W.; Martin, G.P.; Larhrib, H.; Ticehurst, M.D.; Kolosionek, E.; Nokhodchi, A. 2012: The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers Colloids and Surfaces. B Biointerfaces 89: 29-39
Donovan, M.J.; Smyth, H.D.C. 2010: Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations International Journal of Pharmaceutics 402(1-2): 1-9
Le, V.N.P.; Bierend, H.; Robins, E.; Steckel, H.; Flament, M.P. 2012: Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate International Journal of Pharmaceutics 422(1-2): 75-82
Harjunen, P.; Jarvinen, K.; Lehto, V.P.; Lankinen, T. 2003: Performance of salbutamol sulphate and budesonide in a novel dry powder inhaler J. Control. Release 87(1-3): 208-210
Harjunen, P.; Jarvinen, K.; Lehto, V.P.; Lankinen, T. 2003: Performance of salbutamol sulphate and budesonide in a novel dry powder inhaler Journal of Controlled Release 87(1-3): 208-210, 21 February
Zhou, Q.T.; Morton, D.A.V. 2012: Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces Advanced Drug Delivery Reviews 64(3): 275-284
Hertel, M.; Schwarz, E.; Kobler, M.; Hauptstein, S.; Steckel, H.; Scherließ, R. 2018: Powder flow analysis: a simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations International Journal of Pharmaceutics 535(1-2): 59-67
Tammivaara, R.; Aalto, E.; Lehtonen, K.; Vilkka, V.; Laurikainen, K.; Silvasti, M.; Toivanen, P.; Tukiainen, H. 1997: Comparison of a novel salbutamol multidose powder inhaler with a salbutamol metered dose inhaler in patients with asthma Current Therapeutic Research 58(10): 734-744
Randell, J.; Hamalainen, K.-Mari; Leinonen, M.; Keski-Karhu, J.; Silvasti, M.; Tukiainen, H. 2000: Salbutamol via Easyhaler(R) multidose dry powder inhaler produces equivalent relief of histamine-induced bronchoconstriction to salbutamol via pressurised metered-dose inhaler Clinical Drug Investigation 19(5): 335-341
Ferdynand, M.S.; Nokhodchi, A. 2020: Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler Drug Delivery and Translational Research 10(5): 1418-1427
Traini, D.; Young, P.M.; Thielmann, F.; Acharya, M. 2008: The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations Drug Development and Industrial Pharmacy 34(9): 992-1001
Tuli, R.A.; George, G.A.; Dargaville, T.R.; Islam, N. 2012: Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations Pharmaceutical Research 29(9): 2445-2455